These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 25678491)

  • 21. Comparison of [(11)C]Choline ([(11)C]CHO) and [(18)F]Bombesin (BAY 86-4367) as Imaging Probes for Prostate Cancer in a PC-3 Prostate Cancer Xenograft Model.
    Schwarzenböck SM; Schmeja P; Kurth J; Souvatzoglou M; Nawroth R; Treiber U; Kundt G; Berndt S; Graham K; Senekowitsch-Schmidtke R; Schwaiger M; Ziegler SI; Dinkelborg L; Wester HJ; Krause BJ
    Mol Imaging Biol; 2016 Jun; 18(3):393-401. PubMed ID: 26483088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Single center experience of (18F)-fluorocholine positron emission tomography: analysis of its impact on salvage local therapy in patients with prostate adenocarcinoma].
    Moussaid Y; Bonardel G; Jacob J; Métivier D; Gontier E; Bauduceau O; Durand X; Fayolle M; Houlgatte A; Foehrenbach H; Védrine L; Chargari C
    Cancer Radiother; 2013; 17(4):259-64. PubMed ID: 23702489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetics of [(11)C]choline uptake in prostate cancer: a PET study.
    Sutinen E; Nurmi M; Roivainen A; Varpula M; Tolvanen T; Lehikoinen P; Minn H
    Eur J Nucl Med Mol Imaging; 2004 Mar; 31(3):317-24. PubMed ID: 14628097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of
    Palard-Novello X; Beuzit L; Gambarota G; Le Jeune F; Garin E; Salaün PY; Devillers A; Querellou S; Bourguet P; Saint-Jalmes H
    Ann Nucl Med; 2019 Jan; 33(1):47-54. PubMed ID: 30219990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. (18)F-Choline PET/CT imaging of RECIST measurable lesions in hormone refractory prostate cancer.
    Kwee SA; Coel MN; Ly BH; Lim J
    Ann Nucl Med; 2009 Aug; 23(6):541-8. PubMed ID: 19529978
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Grkovski M; Gharzeddine K; Sawan P; Schöder H; Michaud L; Weber WA; Humm JL
    J Nucl Med; 2018 Nov; 59(11):1672-1678. PubMed ID: 29626123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combining image-derived and venous input functions enables quantification of serotonin-1A receptors with [carbonyl-11C]WAY-100635 independent of arterial sampling.
    Hahn A; Nics L; Baldinger P; Ungersböck J; Dolliner P; Frey R; Birkfellner W; Mitterhauser M; Wadsak W; Karanikas G; Kasper S; Lanzenberger R
    Neuroimage; 2012 Aug; 62(1):199-206. PubMed ID: 22579604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma.
    Schuster DM; Votaw JR; Nieh PT; Yu W; Nye JA; Master V; Bowman FD; Issa MM; Goodman MM
    J Nucl Med; 2007 Jan; 48(1):56-63. PubMed ID: 17204699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetic modeling of 3'-deoxy-3'-18F-fluorothymidine for quantitative cell proliferation imaging in subcutaneous tumor models in mice.
    Kim SJ; Lee JS; Im KC; Kim SY; Park SA; Lee SJ; Oh SJ; Lee DS; Moon DH
    J Nucl Med; 2008 Dec; 49(12):2057-66. PubMed ID: 18997037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of MRI-assisted metabolic volumetric parameters provided by simultaneous (18)F-fluorocholine PET/MRI for primary prostate cancer characterization.
    Kim YI; Cheon GJ; Paeng JC; Cho JY; Kwak C; Kang KW; Chung JK; Kim EE; Lee DS
    Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1247-56. PubMed ID: 25759164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A tracer kinetic model for 18F-FHBG for quantitating herpes simplex virus type 1 thymidine kinase reporter gene expression in living animals using PET.
    Green LA; Nguyen K; Berenji B; Iyer M; Bauer E; Barrio JR; Namavari M; Satyamurthy N; Gambhir SS
    J Nucl Med; 2004 Sep; 45(9):1560-70. PubMed ID: 15347725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of simplified methods to measure 18F-FLT uptake changes in EGFR-mutated non-small cell lung cancer patients undergoing EGFR tyrosine kinase inhibitor treatment.
    Frings V; Yaqub M; Hoyng LL; Golla SS; Windhorst AD; Schuit RC; Lammertsma AA; Hoekstra OS; Smit EF; Boellaard R;
    J Nucl Med; 2014 Sep; 55(9):1417-23. PubMed ID: 24970910
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Grkovski M; Kohutek ZA; Schöder H; Brennan CW; Tabar VS; Gutin PH; Zhang Z; Young RJ; Beattie BJ; Zanzonico PB; Huse JT; Rosenblum MK; Blasberg RG; Humm JL; Beal K
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1446-1457. PubMed ID: 31865407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 18F-fluorocholine PET-guided target volume delineation techniques for partial prostate re-irradiation in local recurrent prostate cancer.
    Wang H; Vees H; Miralbell R; Wissmeyer M; Steiner C; Ratib O; Senthamizhchelvan S; Zaidi H
    Radiother Oncol; 2009 Nov; 93(2):220-5. PubMed ID: 19767115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [¹⁸F]-fluorocholine positron-emission/computed tomography for lymph node staging of patients with prostate cancer: preliminary results of a prospective study.
    Dundee PE; Hutton AC; Eden CG
    BJU Int; 2011 Jan; 107(1):158-9; author reply 159. PubMed ID: 21176070
    [No Abstract]   [Full Text] [Related]  

  • 36. Quantification of 11C-Laniquidar Kinetics in the Brain.
    Froklage FE; Boellaard R; Bakker E; Hendrikse NH; Reijneveld JC; Schuit RC; Windhorst AD; Schober P; van Berckel BN; Lammertsma AA; Postnov A
    J Nucl Med; 2015 Nov; 56(11):1730-5. PubMed ID: 26294297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification of 18F-Fluoride Kinetics: Evaluation of Simplified Methods.
    Raijmakers P; Temmerman OP; Saridin CP; Heyligers IC; Becking AG; van Lingen A; Lammertsma AA
    J Nucl Med; 2014 Jul; 55(7):1122-7. PubMed ID: 24868107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognosis Related to Metastatic Burden Measured by ¹⁸F-Fluorocholine PET/CT in Castration-Resistant Prostate Cancer.
    Kwee SA; Lim J; Watanabe A; Kromer-Baker K; Coel MN
    J Nucl Med; 2014 Jun; 55(6):905-10. PubMed ID: 24676753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetic analysis and optimisation of
    Malaspina S; Oikonen V; Kuisma A; Ettala O; Mattila K; Boström PJ; Minn H; Kalliokoski K; Postema EJ; Miller MP; Scheinin M
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3723-3731. PubMed ID: 33846844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a thin layer chromatography method for plasma correction of [
    Villar M; Valiente M; Toscano M; Galmés M; González C; Ortiz M; Vega F; Oporto M; Bibiloni P; Chinchilla JL; Molina J; Ríos Á; Peña C; Rubí S
    Nucl Med Biol; 2019; 74-75():34-40. PubMed ID: 31473490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.